{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:52:45Z","timestamp":1791021165813,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1728,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1468-1331.2010.03273.x","type":"journal-article","created":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T02:28:23Z","timestamp":1291861703000},"page":"865-871","source":"Crossref","is-referenced-by-count":68,"title":["Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases"],"prefix":"10.1111","volume":"18","author":[{"given":"C. E.","family":"Teunissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Veerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"De Vente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. R. J.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vreeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P. J.","family":"van Boxtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F. C.","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A. L.","family":"Pelsers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1212\/WNL.0b013e3181bd8271","article-title":"CSF biomarkers predict rate of cognitive decline in Alzheimer disease","volume":"73","author":"Kester","year":"2009","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archneur.64.7.1007","article-title":"Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome","volume":"64","author":"Schupf","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64","author":"Graff-Radford","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.expneurol.2009.07.024","article-title":"Amyloid beta peptides in plasma in early diagnosis of Alzheimer\u2019s disease: a multicenter study with multiplexing","volume":"223","author":"Lewczuk","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archneurol.2008.565","article-title":"A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease","volume":"66","author":"Xia","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0163-7827(96)00006-9","article-title":"Cellular fatty acid-binding proteins: their function and physiological significance","volume":"35","author":"Glatz","year":"1996","journal-title":"Prog Lipid Res"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1388-1981(00)00046-9","article-title":"The fatty acid transport function of fatty acid-binding proteins","volume":"1486","author":"Storch","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.RES.85.4.329","article-title":"Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene","volume":"85","author":"Schaap","year":"1999","journal-title":"Circ Res"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1385\/JMN:16:2-3:143","article-title":"Collision-mediated transfer of long-chain fatty acids by neural tissue fatty acid-binding proteins (FABP): studies with fluorescent analogs","volume":"16","author":"Thumser","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1073\/pnas.051619898","article-title":"Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus","volume":"98","author":"Wolfrum","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF03194597","article-title":"The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism","volume":"47","author":"Chmurzynska","year":"2006","journal-title":"J Appl Genet"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1242\/dev.120.9.2637","article-title":"The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development","volume":"120","author":"Kurtz","year":"1994","journal-title":"Development"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","article-title":"Fatty acid-binding proteins as plasma markers of tissue injury","volume":"352","author":"Pelsers","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1074\/mcp.M300066-MCP200","article-title":"Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study","volume":"3","author":"Zimmermann-Ivol","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1515\/CCLM.2005.135","article-title":"Detection of brain injury by fatty acid-binding proteins","volume":"43","author":"Pelsers","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1373\/clinchem.2003.030361","article-title":"Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility","volume":"50","author":"Pelsers","year":"2004","journal-title":"Clin Chem"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00415-005-0725-z","article-title":"Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke","volume":"252","author":"Wunderlich","year":"2005","journal-title":"J Neurol"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/pmic.200300478","article-title":"A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease","volume":"3","author":"Guillaume","year":"2003","journal-title":"Proteomics"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jns.2007.08.018","article-title":"Serum heart-fatty acid binding protein levels in patients with Lewy body disease","volume":"266","author":"Wada-Isoe","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2004.07.061","article-title":"Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases","volume":"370","author":"Steinacker","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/jnp.5.1.78","article-title":"Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach","volume":"5","author":"Verhey","year":"1993","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB30|cit30","first-page":"120","article-title":"[The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging]","volume":"29","author":"Jolles","year":"1998","journal-title":"Tijdschr Gerontol Geriatr"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00415-006-0138-7","article-title":"Prevalence of primitive reflexes and the relationship with cognitive change in healthy adults: a report from the Maastricht Aging Study","volume":"253","author":"van Boxtel","year":"2006","journal-title":"J Neurol"},{"issue":"Pt 3","key":"10.1111\/j.1468-1331.2010.03273.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/000456329703400307","article-title":"One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein","volume":"34","author":"Wodzig","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB33|cit33","first-page":"441","article-title":"Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects","volume":"45","author":"Pelsers","year":"1999","journal-title":"Clin Chem"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0197-4580(03)00005-8","article-title":"Combination of serum markers related to several mechanisms in Alzheimer\u2019s disease","volume":"24","author":"Teunissen","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1111\/j.1468-1331.2010.03273.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000105157","article-title":"Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies","volume":"4","author":"Mollenhauer","year":"2007","journal-title":"Neurodegener Dis"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2010.03273.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-1331.2010.03273.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T23:45:56Z","timestamp":1636933556000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2010.03273.x"}},"subtitle":["Brain-specific fatty acid-binding protein in dementia"],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03273.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101"],"issn-type":[{"value":"1351-5101","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}